Aandelen in “Productie van medische instrumenten”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Productie van medische instrumenten”

04:02 · Integer Holdings Corporation Securities Fraud Class Action Result of Overstated Demand and 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC · Persbericht

04:02 · Integer Holdings Corporation Securities Fraud Class Action Result of Overstated Demand and 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC · Persbericht

29/01 · Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results · Persbericht

29/01 · BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care · Persbericht

28/01 · Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

28/01 · Guerbet: Karim Boussebaa appointed Chief Executive Officer · Persbericht

28/01 · Investors in Integer Holdings Corporation Should Contact Levi & Korsinsky Before February 9, 2026 to Discuss Your Rights - ITGR · Persbericht

27/01 · BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26 · Persbericht

27/01 · Form 8.3 - Inspecs Group Plc · Persbericht

27/01 · AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market · Persbericht

27/01 · BD to Announce Financial Results for its First Quarter of Fiscal 2026 · Persbericht

27/01 · BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business · Persbericht

27/01 · Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business · Persbericht

26/01 · Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering · Persbericht

26/01 · CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Integer Holdings Corporation (NYSE: ITGR) Investors to Inquire About a Securities Fraud Class Action by February 9, 2026 · Persbericht

23/01 · Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation · Persbericht

23/01 · BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation · Persbericht

22/01 · Strengthening the blood supply: Awareness, challenges and donor impact · Persbericht

21/01 · Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026 · Persbericht

21/01 · Atossa Therapeutics' Founder and CEO Steven Quay, M.D., Ph.D. Named One of The Top 50 Healthcare Technology CEOs of 2025 · Persbericht

21/01 · Shareholders that lost money on Integer Holdings Corporation(ITGR) should contact Levi & Korsinsky about pending Class Action - ITGR · Persbericht

Mijn selecties